Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ
26.66
-0.38(-1.41%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
26.66
-0.38(-1.41%)
Currency In CNY
| Market Cap | 2.26B |
| Enterprise Value | 3.38B |
| P/E Ratio | -39.9 |
| PEG Ratio | 0.54 |
| Price/Sales Ratio | 4.89 |
| Price/Book Ratio | 3.43 |
| Enterprise/Revenue | 6.71 |
| Enterprise/EBITDA | 79.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.11 |
| Operating Margin | -0.16 |
| Return On Assets | -0.02 |
| Return On Equity | -0.08 |
| Revenue | 606.18M |
| Revenue/Share | 5.9 |
| Gross Profit | 83.5M |
| EBITDA | 57.93M |
| Net Income | -73.36M |
| Diluted EPS | -0.64 |
| Total Cash | 75.48M |
| Total Cash/Share | 0.71 |
| Total Debt | 1.22B |
| Total Debt/Equity | 1.47 |
| Current Ratio | 0.99 |
| Book Value Per Share | 8.54 |
| 52-Week Change | 49.69 |
| 52-Week High | 29.77 |
| 52-Week Low | 17.01 |
| Moving Average 50 Days | 24.16 |
| Moving Average 200 Days | 22.13 |
| Average Volume | 3.78M |
| Shares Outstanding | 115.28M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.37 |
| Last Split Factor | N/A |
| Last Split Date | N/A |